HUMANIZATION OF MURINE MONOCLONAL-ANTIBODIES THROUGH VARIABLE DOMAIN RESURFACING

被引:161
作者
ROGUSKA, MA
PEDERSEN, JT
KEDDY, CA
HENRY, AH
SEARLE, SJ
LAMBERT, JM
GOLDMACHER, VS
BLATTLER, WA
REES, AR
GUILD, BC
机构
[1] IMMUNOGEN INC, 148 SIDNEY ST, CAMBRIDGE, MA 02139 USA
[2] UNIV BATH, DEPT BIOCHEM, BATH BA2 7AY, AVON, ENGLAND
关键词
D O I
10.1073/pnas.91.3.969
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Two murine monoclonal antibodies, N901 (anti-CD56) and anti-B4 (anti-CD19), were humanized by a process we call ''resurfacing.'' A systematic analysis of known antibody structures has been used to determine the relative solvent accessibility distributions of amino acid residues in murine and human antibody variable (Fv) regions and has shown that the sequence alignment positions of surface amino acids for human and murine variable region heavy (V(H)) and light (V(L)) chains are conserved with 98% fidelity across species. While the amino acid usage at these surface positions creates surface residue patterns that are conserved within species, there are no identical patterns across species. However, surprisingly few amino acid changes need to be made to convert a murine Fv surface pattern to that characteristic of a human surface. Resurfacing was used to change the patterns of surface accessible residues in the Fv regions of the N901 and anti-B4 antibodies to resemble those found on the Fv regions of human antibody sequences. Two different procedures for selecting a human sequence were compared. For anti-B4, a data base of clonally derived human V(L)-V(H) sequence pairs was used, while for N901, sequences for V(L) and V(H) were independently selected from the Kabat et al. data base [Kabat, E. A., Wu, T. T., Reid-Miller, M., Perry, H. M. & Gottesman, K. S. (1991) Sequences of Proteins of Immunological Interest (DHHS, Washington, DC), 5th Ed.]. Resurfaced N901 and anti-B4 antibodies had apparent affinities for their cell surface ligands that were identical to those of their respective parent murine antibodies. These data provide evidence that, despite the differences in the surfaces of mouse and human Fv regions, it is possible to substitute one for the other while retaining full antigen binding affinity.
引用
收藏
页码:969 / 973
页数:5
相关论文
共 42 条
[1]   ONE CELL-ONE IMMUNOGLOBULIN . ORIGIN OF LIMITED HETEROGENEITY OF MYELOMA PROTEINS [J].
AWDEH, ZL ;
WILLIAMS.AR ;
ASKONAS, BA .
BIOCHEMICAL JOURNAL, 1970, 116 (02) :241-&
[2]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[3]   CONTINUING REARRANGEMENT BUT ABSENCE OF SOMATIC HYPERMUTATION IN IMMUNOGLOBULIN GENES OF HUMAN B-CELL PRECURSOR LEUKEMIA [J].
BIRD, J ;
GALILI, N ;
LINK, M ;
STITES, D ;
SKLAR, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (01) :229-245
[4]   CONSTRUCTION OF VALIDATED, NONREDUNDANT COMPOSITE PROTEIN-SEQUENCE DATABASES [J].
BLEASBY, AJ ;
WOOTTON, JC .
PROTEIN ENGINEERING, 1990, 3 (03) :153-159
[5]   PREDICTION OF THE FOLDING OF SHORT POLYPEPTIDE SEGMENTS BY UNIFORM CONFORMATIONAL SAMPLING [J].
BRUCCOLERI, RE ;
KARPLUS, M .
BIOPOLYMERS, 1987, 26 (01) :137-168
[6]   CONFORMATIONS OF IMMUNOGLOBULIN HYPERVARIABLE REGIONS [J].
CHOTHIA, C ;
LESK, AM ;
TRAMONTANO, A ;
LEVITT, M ;
SMITHGILL, SJ ;
AIR, G ;
SHERIFF, S ;
PADLAN, EA ;
DAVIES, D ;
TULIP, WR ;
COLMAN, PM ;
SPINELLI, S ;
ALZARI, PM ;
POLJAK, RJ .
NATURE, 1989, 342 (6252) :877-883
[7]   POLYMERASE CHAIN-REACTION FACILITATES THE CLONING, CDR-GRAFTING, AND RAPID EXPRESSION OF A MURINE MONOCLONAL-ANTIBODY DIRECTED AGAINST THE CD18 COMPONENT OF LEUKOCYTE INTEGRINS [J].
DAUGHERTY, BL ;
DEMARTINO, JA ;
LAW, MF ;
KAWKA, DW ;
SINGER, II ;
MARK, GE .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2471-2476
[8]  
FASULLO FJ, 1989, CLIN CHEM, V35, P364
[9]   ANTIBODY FRAMEWORK RESIDUES AFFECTING THE CONFORMATION OF THE HYPERVARIABLE LOOPS [J].
FOOTE, J ;
WINTER, G .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 224 (02) :487-499
[10]  
GOLDMACHER VS, 1986, J IMMUNOL, V136, P320